CTLA4 and pneumonia: Severe pneumonia was observed upon non-specific administration of anti-CTLA4 i.p. or to ntbLN, likely due to disruption of normal immune system homeostasis by ICI at a site critical to mounting immune response because of non-specific activation [60].